Shingles in cancer patients: a hidden cost burden?

NCT ID NCT06207487

Completed Knowledge-focused Sponsor: AC Camargo Cancer Center Source: ClinicalTrials.gov ↗

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This study looks back at medical records of 150 adults with active cancer who had a confirmed case of shingles (herpes zoster). The goal is to understand the clinical features of shingles in these patients, such as how it spreads and complications like long-term nerve pain, and to estimate the direct hospital costs from emergency visits and hospitalizations. By analyzing this data, researchers hope to inform future cost-effectiveness analyses of shingles vaccination in oncology populations.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could provide data to support cost-effectiveness analyses of shingles vaccination in cancer patients, potentially leading to better prevention strategies.
What could go wrong: This is an observational study, so it cannot prove cause and effect. Results may be limited to a single Brazilian cancer center and may not generalize to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HERPES ZOSTER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

herpes zoster neoplasm Neuralgia, Postherpetic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HERPES ZOSTER

Contacts and locations

Locations

A.C.Camargo Cancer Center

São Paulo, São Paulo, 01509-001, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.